A health care analyst at TD Cowen who explores topics related to artificial intelligence and biosimulation.
Referenced in coverage
“Led proprietary survey of 80 biopharma leaders on AI's impact on drug development costs and timelines, finding AI compresses preclinical costs by up to 70%.”